|
‘Pharma
is a defensive sector’
The Sensex has reached the 17,000 mark. What does it mean
for Indian Pharma? Nandini Patwardhan speaks to Aditi Kare
Panandikar, Director-Business Development, Indoco Remedies,
given that the stock was oscillating in the Rs 200-400 band
'Swagelok
is a club of entrepreneurs'
Swagelok , a premier player offering
fluid system products, has progressively tapped most of the
sectors, and is still expanding its global footprint. Amit
Advani, Managing Director, Swagelok, Mumbai, and Mike Bridge,
Sanitary Projects Manager, Swagelok Biopharm Services Company,
share their views about the company with Nandini Patwardhan
India
is the 'destination'
Anil Bhasin talks about networking technology that will help
hasten Indian pharma industry's growth as the perfect offshoring
hub
More
than just a bio-pharma consultancy
Bioasset Technologies was founded by Manjiri Ashtekar in 2002,
to provide services in terms of consultancy, project management
and turnkey solutions to the biotech, pharma, nutraceutical
and life sciences segments.
Launching
of a brand
Ujjal Chatterjee gives an insight into what goes on behind
the scenes of a product launch
Ten
guaranteed ways for project success
The clinical trial industry is on an upswing, but the road
to success can be a slippery slope. S Lakshmanan outlines
ten ways to guarantee success
|
